Yonezawa, Japan

Kazuhiro Satou

This inventor holds 1 USPTO granted patent. Top assignee: Hitachi Chemical Company, Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Satou. Retrieved from https://idiyas.com/inventor/kazuhiro-satou-7lth6a5u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhiro Satou: Innovator in Cancer Cell Adhesiveness

Introduction

Kazuhiro Satou is a notable inventor based in Yonezawa, Japan. He has made significant contributions to the field of cancer research through his innovative work on improving cancer cell adhesiveness.

Latest Patents

Kazuhiro Satou holds 1 patent for an agent designed to enhance cancer cell adhesiveness. His patent describes a polymer that includes a constitutional unit represented by a specific formula. This polymer is particularly useful when applied to the surface of a cancer cell enrichment filter, as it improves the adhesiveness of cancer cells to the filter surface. Consequently, this enhancement leads to an improved enrichment ratio of cancer cells, which is crucial for effective cancer treatment.

Career Highlights

Kazuhiro Satou is associated with Hitachi Chemical Company, Ltd., where he has been able to apply his expertise in polymer chemistry to develop innovative solutions for cancer research. His work has the potential to significantly impact the way cancer cells are isolated and studied.

Collaborations

Throughout his career, Kazuhiro has collaborated with esteemed colleagues such as Hisashige Kanbara and Masaru Tanaka. These collaborations have fostered a productive environment for innovation and research in cancer cell technology.

Conclusion

Kazuhiro Satou's contributions to cancer research through his innovative patent demonstrate his commitment to advancing medical science. His work not only enhances the understanding of cancer cell behavior but also paves the way for improved treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…